. 2009 Feb 18;2:1–15.

Table 3.

Current adjuvant studies utilizing bevacizumab in colorectal cancer

Adjuvant studies	Chemotherapy regimen	n
AVANT⁷⁴	FOLFOX-4 vs FOLFOX-4 plus bevacizumab vs XELOX plus bevacizumab	3450
NSABP C-08⁷⁸	mFOLFOX6 with and without bevacizumab	2632
E 5202⁷⁶	FOLFOX with and without bevacizumab	3610
QUASAR 2⁷⁸	Capecitabine with and without bevacizumab	2240